CriterionyxInsights
We are driven by a singular vision - Health for All. Criterionyx Insights turns complex data into actionable insights for community safety and wellness, bridging the gap between rigorous analysis and the decisions that protect public health.
Dr. Abida Anwar is an epidemiologist, biotechnology scientist, and data strategist with more than 15 years of experience spanning biotechnology research, biochemistry, disease surveillance, environmental health, pharmacovigilance, and advanced analytics.
She holds a Ph.D. in Biotechnology and a Master of Public Health in Environmental Health, bringing a unique multidisciplinary perspective that connects laboratory science, population health, and data-driven decision-making. Her scientific background includes molecular biology, microbiology, protein and enzyme characterization, biotechnology research, diagnostic reagent development, clinical pathology, and neuropharmacology. Throughout her research career, she has authored scientific publications and presented her work at national and international conferences.
In public health, Dr. Anwar has led epidemiologic investigations, disease surveillance initiatives, and predictive analytics projects focused on emerging infectious diseases, environmental exposures, chronic disease outcomes, and healthcare preparedness. Her expertise includes statistical modeling, machine learning, real-world evidence generation, geographic health analysis, and population health surveillance using large and complex datasets.
As Founder of Criterionyx Insights, Dr. Anwar helps organizations transform complex data into evidence-based strategies across environmental health and justice, pharmacovigilance, disease surveillance, and public health research. Her work combines scientific rigor, analytical expertise, and practical insight to help clients identify risks, uncover meaningful patterns, and make informed decisions that improve health outcomes and community well-being.
Dr. Anwar's mission is simple: to translate science and data into actionable intelligence that drives healthier communities, safer products, and more effective public health solutions.
Connect with Dr. Anwar →Her core expertise is built on high-impact, multi-disciplinary projects, including:
Mapping localized cancer risks at the 97th percentile in Harris County.
Conducting disproportionality analyses of FDA FAERS data to identify safety signals in medication reporting.
Implementing data-driven response strategies for communicable, emerging, and non-communicable diseases.
Developing supervised machine learning models to forecast COVID-19 hospitalization trends using Harris County Public Health data (Presented at APHA 2023).
Criterionyx Insights was inspired by the goal of "Health for All" - bridging the gap between complex data and community safety. Our unique approach draws expertise across environmental toxicology, pharmacovigilance, and disease surveillance.
Whether we are analyzing safety signals in medication reporting or mapping industrial air pollutants, we provide the rigorous data analysis and response strategies needed to protect public health. We deliver the evidence-based solutions organizations need to achieve total community wellness.
Tell us what you're working on. We'll show you how an evidence-based analysis would approach it.